Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Head/Neck Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00894413
What this trial is testing

A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 45
Early research (Phase 1)Looking for participantsNCT05107674
What this trial is testing

NX-1607 in Adults With Advanced Malignancies

Who this might be right for
Ovarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more
Nurix Therapeutics, Inc. 345
Early research (Phase 1)Study completedNCT00593723
What this trial is testing

IMRT Tomotherapy for Esophagus Cancer

Who this might be right for
Esophagus Cancer
Washington University School of Medicine 26
Large-scale testing (Phase 3)UnknownNCT01880359
What this trial is testing

AF CRT +/- Nimorazole in HNSCC

Who this might be right for
Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers
European Organisation for Research and Treatment of Cancer - EORTC 640
Not applicableStudy completedNCT03948724
What this trial is testing

Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

Who this might be right for
Therapeutic Patient EducationImmune Checkpoint InhibitorsMelanoma+4 more
Institut Cancerologie de l'Ouest 412
Testing effectiveness (Phase 2)Looking for participantsNCT04900623
What this trial is testing

Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study

Who this might be right for
HPV-Associated Oropharyngeal Squamous Cell CarcinomaHPV Positive Oropharyngeal Squamous Cell CarcinomaHPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Stage+9 more
Jonathan Schoenfeld, MD, MPH 145
Not applicableLooking for participantsNCT06767488
What this trial is testing

Breathomics in the Diagnosis and Prediction of Radiotherapy-Induced Oropharyngeal Mucositis in Head and Neck Tumors

Who this might be right for
Head and Neck TumorsBreathomicsVolatile Organic Compounds+1 more
Nanfang Hospital, Southern Medical University 375
Testing effectiveness (Phase 2)Study completedNCT04666688
What this trial is testing

LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic CancerSolid TumorPancreatic Cancer+3 more
PureTech 44
Not applicableStudy completedNCT04797390
What this trial is testing

A Study Evaluating an Advanced Pneumatic Compression Device Versus Usual Care for Treatment of Head and Neck Lymphedema

Who this might be right for
LymphedemaLymphedema of FaceLymphedema, Secondary+2 more
Tactile Medical 236
Testing effectiveness (Phase 2)Study completedNCT03217188
What this trial is testing

Proton Re-Irradiation for Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Memorial Sloan Kettering Cancer Center 87
Early research (Phase 1)Ended earlyNCT03799003
What this trial is testing

ASP1951 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Global Development, Inc. 119
Testing effectiveness (Phase 2)Active Not RecruitingNCT04373642
What this trial is testing

"QUAD SHOT" Radiotherapy With Pembrolizumab in Patients With Recurrent Head & Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Oklahoma 30
Not applicableStudy completedNCT00480428
What this trial is testing

Radiation Exposure and Thyroid Disease in Kazakhstan

Who this might be right for
Thyroid CancerThyroid NodulesOther Thyroid Disease
National Cancer Institute (NCI) 117
Early research (Phase 1)Study completedNCT03538028
What this trial is testing

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Who this might be right for
Cervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more
Incyte Biosciences International Sàrl 22
Not applicableUnknownNCT03450447
What this trial is testing

Outcomes of A Novel Treatment Decision of Patients With Esophageal and Head and Neck Carcinoma Synchronously

Who this might be right for
Head and Neck CancerEsophageal Cancer Stage
Yanqing Li 20
Not applicableNot Yet RecruitingNCT06411834
What this trial is testing

Mapping Patient Decision-making in Thyroid Cancer

Who this might be right for
Thyroid Cancer
University of California, Los Angeles 50
Not applicableUnknownNCT05510609
What this trial is testing

Three-dimensional Ultrasonography Thyroid Volume Measurement.

Who this might be right for
ThyroidThyroid CancerThyroid Diseases+3 more
Rigshospitalet, Denmark 17
Testing effectiveness (Phase 2)Study completedNCT02296684
What this trial is testing

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Who this might be right for
Cancer of Head and NeckHead and Neck CancerNeoplasms, Head and Neck+3 more
Washington University School of Medicine 67
Testing effectiveness (Phase 2)Looking for participantsNCT07325539
What this trial is testing

LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Nasopharangeal Cancer
Sun Yat-sen University 55
Testing effectiveness (Phase 2)UnknownNCT06130007
What this trial is testing

A Prospective, Single-arm Phase II Clinical Trial of Tislelizumab Combined With Platinum Doublet Neoadjuvant Therapy to Improve Mandibular Preservation in Resectable Locally Advanced Oral Squamous Cell Carcinoma.

Who this might be right for
Oral Squamous Cell Carcinoma
Xuekui Liu 48
Next Page